Clinical trial

Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus

NCT04484259

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-31

PhasePHASE4

Study timeline

Study start (actual)2021-03-31Date precision: day

Registry last updated2025-03-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Coronary Artery Diseaseunresolved

Interventions

Ticagrelor monotherapyDRUG

Ticagrelor plus aspirinDRUG

Clopidogrel with aspirinDRUG

Sponsors & collaborators

University of Floridalead sponsor

AstraZenecacollaborator

Mapped research locations

JacksonvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04484259 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.